Healthcare costs of transarterial chemoembolization in the treatment of hepatocellular carcinoma. (2017)
Attributed to:
Nottingham Molecular Pathology Node (NMPN) for Integrated Multi-platform Biomarker Research and Knowledge Transfer
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.2147/jhc.s144068
PubMed Identifier: 29082223
Publication URI: http://europepmc.org/abstract/MED/29082223
Type: Journal Article/Review
Volume: 4
Parent Publication: Journal of hepatocellular carcinoma
ISSN: 2253-5969